Tahoe Bio is a biotechnology company developing foundational AI-driven models of the human cell using gigascale single-cell maps to understand how drug molecules interact with diverse patient biology. Their platform generates hundreds of millions of perturbational single-cell data points to map chemistry’s effects on cells, enabling precision drug discovery for cancer and other diseases. With a focus on virtual cell models and biology-first data, Tahoe Bio aims to accelerate discovery and translation to the clinic, starting from cancer. The company is based in South San Francisco, California, and has publicly announced open-source data initiatives and partnerships to advance biological AI research.
No recent deals for this company.